These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 32636949)

  • 21. Stimuli-responsive chitosan-based nanocarriers for cancer therapy.
    Fathi M; Sahandi Zangabad P; Majidi S; Barar J; Erfan-Niya H; Omidi Y
    Bioimpacts; 2017; 7(4):269-277. PubMed ID: 29435435
    [No Abstract]   [Full Text] [Related]  

  • 22. Glutathione and Reactive Oxygen Species Dual-Responsive Block Copolymer Prodrugs for Boosting Tumor Site-Specific Drug Release and Enhanced Antitumor Efficacy.
    Yin W; Ke W; Lu N; Wang Y; Japir AAMM; Mohammed F; Wang Y; Pan Y; Ge Z
    Biomacromolecules; 2020 Feb; 21(2):921-929. PubMed ID: 31961134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emerging Strategies in Stimuli-Responsive Nanocarriers as the Drug Delivery System for Enhanced Cancer Therapy.
    Saravanakumar K; Hu X; Ali DM; Wang MH
    Curr Pharm Des; 2019; 25(24):2609-2625. PubMed ID: 31603055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor microenvironment and redox dual stimuli-responsive polymeric nanoparticles for the effective cisplatin-based cancer chemotherapy.
    Jia YY; Huan ML; Wang W; Jia ZY; Wan YH; Zhou SY; Zhang BL
    Nanotechnology; 2022 Nov; 34(3):. PubMed ID: 36219885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biodegradable, Hydrogen Peroxide, and Glutathione Dual Responsive Nanoparticles for Potential Programmable Paclitaxel Release.
    Chen D; Zhang G; Li R; Guan M; Wang X; Zou T; Zhang Y; Wang C; Shu C; Hong H; Wan LJ
    J Am Chem Soc; 2018 Jun; 140(24):7373-7376. PubMed ID: 29799737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reactive oxygen species and glutathione dual redox-responsive micelles for selective cytotoxicity of cancer.
    Chiang YT; Yen YW; Lo CL
    Biomaterials; 2015 Aug; 61():150-61. PubMed ID: 26002788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A reactive oxygen species-replenishing coordination polymer nanomedicine disrupts redox homeostasis and induces concurrent apoptosis-ferroptosis for combinational cancer therapy.
    Zhang Z; Pan Y; Cun JE; Li J; Guo Z; Pan Q; Gao W; Pu Y; Luo K; He B
    Acta Biomater; 2022 Oct; 151():480-490. PubMed ID: 35926781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glutathione and Esterase Dual-Responsive Smart Nano-drug Delivery System Capable of Breaking the Redox Balance for Enhanced Tumor Therapy.
    Shen P; Zhang X; Ding N; Zhou Y; Wu C; Xing C; Zeng L; Du L; Yuan J; Kang Y
    ACS Appl Mater Interfaces; 2023 May; 15(17):20697-20711. PubMed ID: 37083309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation and application of pH-responsive drug delivery systems.
    Ding H; Tan P; Fu S; Tian X; Zhang H; Ma X; Gu Z; Luo K
    J Control Release; 2022 Aug; 348():206-238. PubMed ID: 35660634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Active targeting redox-responsive mannosylated prodrug nanocolloids promote tumor recognition and cell internalization for enhanced colon cancer chemotherapy.
    Gao Y; Qiu W; Liang M; Ma X; Ye M; Xue P; Kang Y; Deng J; Xu Z
    Acta Biomater; 2022 Jul; 147():299-313. PubMed ID: 35640802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Facile preparation of pH/redox dual-responsive biodegradable polyphosphazene prodrugs for effective cancer chemotherapy.
    Wang D; Zhou N; Zhang N; Zhi Z; Shao Y; Meng L; Yu D
    Colloids Surf B Biointerfaces; 2021 Apr; 200():111573. PubMed ID: 33476954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advances in the stimuli-responsive mesoporous silica nanoparticles as drug delivery system nanotechnology for controlled release and cancer therapy.
    Zhu Y; Bai Y; He J; Qiu X
    3 Biotech; 2023 Aug; 13(8):274. PubMed ID: 37457870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent Advancements in Stimuli Responsive Drug Delivery Platforms for Active and Passive Cancer Targeting.
    Rahim MA; Jan N; Khan S; Shah H; Madni A; Khan A; Jabar A; Khan S; Elhissi A; Hussain Z; Aziz HC; Sohail M; Khan M; Thu HE
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33562376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endogenous and Exogenous Stimuli-Responsive Drug Delivery Systems for Programmed Site-Specific Release.
    Raza A; Rasheed T; Nabeel F; Hayat U; Bilal M; Iqbal HMN
    Molecules; 2019 Mar; 24(6):. PubMed ID: 30901827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery.
    Cheng R; Meng F; Deng C; Klok HA; Zhong Z
    Biomaterials; 2013 May; 34(14):3647-57. PubMed ID: 23415642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Classification of stimuli-responsive polymers as anticancer drug delivery systems.
    Taghizadeh B; Taranejoo S; Monemian SA; Salehi Moghaddam Z; Daliri K; Derakhshankhah H; Derakhshani Z
    Drug Deliv; 2015 Feb; 22(2):145-55. PubMed ID: 24547737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. pH and redox dual-responsive copolymer micelles with surface charge reversal for co-delivery of all-
    Zhang Y; Peng L; Chu J; Zhang M; Sun L; Zhong B; Wu Q
    Int J Nanomedicine; 2018; 13():6499-6515. PubMed ID: 30410335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Smart stimuli-responsive drug delivery systems in spotlight of COVID-19.
    Najjari Z; Sadri F; Varshosaz J
    Asian J Pharm Sci; 2023 Nov; 18(6):100873. PubMed ID: 38173712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent progress of redox-responsive polymeric nanomaterials for controlled release.
    Hsu PH; Almutairi A
    J Mater Chem B; 2021 Mar; 9(9):2179-2188. PubMed ID: 33616136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. pH/Reductant Dual-Responsive Core-Cross-Linked Micelles via Facile in Situ ATRP for Tumor-Targeted Delivery of Anticancer Drug with Enhanced Anticancer Efficiency.
    Tian K; Jia X; Zhao X; Liu P
    Mol Pharm; 2016 Aug; 13(8):2683-90. PubMed ID: 27379461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.